NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 58 filers reported holding NEOGENOMICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $4,310,000 | -7.9% | 546,303 | 0.0% | 0.54% | -7.1% |
Q4 2016 | $4,681,000 | +8.4% | 546,303 | +4.0% | 0.58% | -8.2% |
Q3 2016 | $4,317,000 | +2.9% | 525,223 | +0.7% | 0.63% | +16.0% |
Q2 2016 | $4,194,000 | -6.8% | 521,652 | -21.9% | 0.54% | +5.6% |
Q1 2016 | $4,501,000 | +6.9% | 667,824 | +24.8% | 0.52% | +13.9% |
Q4 2015 | $4,212,000 | -28.3% | 535,264 | -47.8% | 0.45% | -21.5% |
Q3 2015 | $5,874,000 | -42.4% | 1,025,191 | -45.6% | 0.58% | -25.6% |
Q2 2015 | $10,193,000 | -13.3% | 1,884,186 | -25.1% | 0.77% | -5.8% |
Q1 2015 | $11,752,000 | +27.3% | 2,516,656 | +13.7% | 0.82% | +34.5% |
Q4 2014 | $9,233,000 | -13.7% | 2,214,203 | +7.8% | 0.61% | -17.2% |
Q3 2014 | $10,696,000 | +45.0% | 2,053,054 | -7.6% | 0.74% | +60.8% |
Q2 2014 | $7,376,000 | +8.0% | 2,221,839 | +12.8% | 0.46% | +12.5% |
Q1 2014 | $6,832,000 | +18.2% | 1,969,026 | +23.3% | 0.41% | +27.9% |
Q4 2013 | $5,781,000 | +27.1% | 1,596,976 | +5.3% | 0.32% | +11.9% |
Q3 2013 | $4,550,000 | -25.6% | 1,516,990 | -1.3% | 0.28% | -29.8% |
Q2 2013 | $6,117,000 | – | 1,536,990 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |